Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Key facts

Sponsor

VA Office of Research and Development

Principal Investigator

Katherine Turk, MD

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Intervention

No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan.(device)

Enrollment

800 enrolled

Eligibility

30-90 years · All sexes

Timeline

2021 – 2026

Study locations (1)

• VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States

Collaborators

VA Boston Healthcare System

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Dementia pugilistica

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07521384
  Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
  Healing Hope International
• RECRUITINGPHASE3NCT06254469
  Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
  CereMark Pharma, LLC
• ENROLLING BY INVITATIONNCT06860828
  The DIAGNOSE CTE Research Project-II
  Boston University
• RECRUITINGNCT07302503
  Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions
  University Hospital, Strasbourg, France
• RECRUITINGNCT03218332
  Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary Study
  University Health Network, Toronto

See all trials for Dementia pugilistica →